Drug intelligence / Profile preview

TF037

Development stage
Phase 1
Lead developer
Norgine
Modality
Small Molecules
Administration
Rectal
01

Overview

TF037 is a low-volume, phosphate-free enema developed by Norgine for distal bowel cleansing prior to medical procedures such as flexible sigmoidoscopy or surgery. The formulation consists of macrogol 3350 (polyethylene glycol 3350) combined with electrolytes, including sodium chloride, sodium bicarbonate, and potassium chloride. As an osmotic laxative, TF037 works by drawing water into the distal colon, which softens the stool and stimulates a bowel movement. This phosphate-free approach is intended to mitigate the risks of electrolyte imbalances and renal toxicity associated with traditional sodium phosphate enemas (such as Fleet Enema), making it a potentially safer option for elderly patients or those with renal impairment. The drug has been evaluated in Phase 3 clinical trials to demonstrate its performance and safety in distal bowel preparation.

Other names
macrogol 3350 + electrolytes enemaPEG 3350 enemaPEG3350 enemaPEG-3350 enemaphosphate-free enema

Beyond the preview

Go deeper on TF037.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TF037.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call